Belvedere Trading »

Black Diamond Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $32k 11k 2.87
2022-12-31 $63k 35k 1.80

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Black Diamond Therapeutics

Bellevue Group
NEA Management Company
RA Capital Management
Artal Group
Vanguard Group
Tang Capital Management
Jpmorgan Chase & Co
Kennedy Capital Management
Blue Owl Capital Holdings
Ikarian Capital
Candriam Luxembourg S.C.A.
Boxer Capital
Two Sigma Investments
Newtyn Management
Barclays

View all funds holding Black Diamond Therapeutics